CN1104427C - 法呢基蛋白转移酶的三环抑制剂 - Google Patents

法呢基蛋白转移酶的三环抑制剂 Download PDF

Info

Publication number
CN1104427C
CN1104427C CN97199598A CN97199598A CN1104427C CN 1104427 C CN1104427 C CN 1104427C CN 97199598 A CN97199598 A CN 97199598A CN 97199598 A CN97199598 A CN 97199598A CN 1104427 C CN1104427 C CN 1104427C
Authority
CN
China
Prior art keywords
compound
formula
compounds
tumor cells
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN97199598A
Other languages
English (en)
Chinese (zh)
Other versions
CN1237165A (zh
Inventor
A·G·塔韦拉斯
A·K·马拉姆斯
A·阿福索
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Sharp and Dohme LLC
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of CN1237165A publication Critical patent/CN1237165A/zh
Application granted granted Critical
Publication of CN1104427C publication Critical patent/CN1104427C/zh
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Dental Preparations (AREA)
  • Cereal-Derived Products (AREA)
  • Enzymes And Modification Thereof (AREA)
CN97199598A 1996-09-13 1997-09-11 法呢基蛋白转移酶的三环抑制剂 Expired - Fee Related CN1104427C (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US71332396A 1996-09-13 1996-09-13
US08/713,323 1996-09-13
US08/713323 1996-09-13

Publications (2)

Publication Number Publication Date
CN1237165A CN1237165A (zh) 1999-12-01
CN1104427C true CN1104427C (zh) 2003-04-02

Family

ID=24865689

Family Applications (1)

Application Number Title Priority Date Filing Date
CN97199598A Expired - Fee Related CN1104427C (zh) 1996-09-13 1997-09-11 法呢基蛋白转移酶的三环抑制剂

Country Status (20)

Country Link
EP (1) EP0929545B1 (enExample)
JP (1) JP2001500510A (enExample)
KR (1) KR20000036120A (enExample)
CN (1) CN1104427C (enExample)
AT (1) ATE286046T1 (enExample)
AU (1) AU4337997A (enExample)
BR (1) BR9712831A (enExample)
CA (1) CA2266016C (enExample)
CZ (1) CZ84399A3 (enExample)
DE (1) DE69732120T2 (enExample)
ES (1) ES2235252T3 (enExample)
HU (1) HUP0000121A2 (enExample)
ID (1) ID21699A (enExample)
IL (1) IL128928A0 (enExample)
NO (1) NO991234L (enExample)
NZ (1) NZ334453A (enExample)
PL (1) PL332242A1 (enExample)
SK (1) SK33899A3 (enExample)
TR (1) TR199901276T2 (enExample)
WO (1) WO1998011093A1 (enExample)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LT3962B (en) 1993-12-21 1996-05-27 Albright & Wilson Funcional fluids
US5939416A (en) * 1997-06-17 1999-08-17 Schering Corporation Benzo (5,6) cycloheptapyridine compounds useful as farnesyl protein transferase inhibitors
ATE309249T1 (de) 1998-01-21 2005-11-15 Millennium Pharm Inc Chemokin rezeptor antagonisten und verwndung
WO1999037619A1 (en) 1998-01-21 1999-07-29 Millennium Pharmaceuticals, Inc. Chemokine receptor antagonists and methods of use therefor
US6509346B2 (en) 1998-01-21 2003-01-21 Millennium Pharmaceuticals, Inc. Chemokine receptor antagonists and methods of use therefor
US6613905B1 (en) 1998-01-21 2003-09-02 Millennium Pharmaceuticals, Inc. Chemokine receptor antagonists and methods of use therefor
US6288083B1 (en) 1998-09-04 2001-09-11 Millennium Pharmaceuticals, Inc. Chemokine receptor antagonists and methods of use therefor
US6503926B2 (en) 1998-09-04 2003-01-07 Millennium Pharmaceuticals, Inc. Chemokine receptor antagonists and methods of use therefor
US7271176B2 (en) 1998-09-04 2007-09-18 Millennium Pharmaceuticals, Inc. Chemokine receptor antagonists and methods of use thereof
US7541365B2 (en) 2001-11-21 2009-06-02 Millennium Pharmaceuticals, Inc. Chemokine receptor antagonists and methods of use therefor
TWI291467B (en) 2002-11-13 2007-12-21 Millennium Pharm Inc CCR1 antagonists and methods of use therefor
US9579088B2 (en) 2007-02-20 2017-02-28 Board Of Regents Of The University Of Nebraska Methods, systems, and devices for surgical visualization and device manipulation
US8679096B2 (en) 2007-06-21 2014-03-25 Board Of Regents Of The University Of Nebraska Multifunctional operational component for robotic devices
TW200902007A (en) * 2007-05-25 2009-01-16 Astrazeneca Ab Spirocyclopropyl piperidine derivatives
EP3078344B1 (en) 2007-07-12 2020-02-26 Board of Regents of the University of Nebraska Actuation in robotic devices
JP2010536435A (ja) 2007-08-15 2010-12-02 ボード オブ リージェンツ オブ ザ ユニバーシティ オブ ネブラスカ 医療用膨張、取り付けおよび送達装置、ならびに関連する方法
EP2717796B1 (en) 2011-06-10 2020-02-26 Board of Regents of the University of Nebraska In vivo vessel sealing end effector
EP2732344B1 (en) 2011-07-11 2019-06-05 Board of Regents of the University of Nebraska Robotic surgical system
EP3730031A1 (en) 2011-10-03 2020-10-28 Board of Regents of the University of Nebraska Robotic surgical devices and systems
WO2013106569A2 (en) 2012-01-10 2013-07-18 Board Of Regents Of The University Of Nebraska Methods, systems, and devices for surgical access and insertion
EP2844181B1 (en) 2012-05-01 2021-03-10 Board of Regents of the University of Nebraska Single site robotic device and related systems
US9010214B2 (en) 2012-06-22 2015-04-21 Board Of Regents Of The University Of Nebraska Local control robotic surgical devices and related methods
US9770305B2 (en) 2012-08-08 2017-09-26 Board Of Regents Of The University Of Nebraska Robotic surgical devices, systems, and related methods
CA2880622C (en) 2012-08-08 2021-01-12 Board Of Regents Of The University Of Nebraska Robotic surgical devices, systems and related methods
US9743987B2 (en) 2013-03-14 2017-08-29 Board Of Regents Of The University Of Nebraska Methods, systems, and devices relating to robotic surgical devices, end effectors, and controllers
CA2906672C (en) 2013-03-14 2022-03-15 Board Of Regents Of The University Of Nebraska Methods, systems, and devices relating to force control surgical systems
CA2906772C (en) 2013-03-15 2021-09-21 Board Of Regents Of The University Of Nebraska Robotic surgical devices, systems and related methods
CA2918531A1 (en) 2013-07-17 2015-01-22 Board Of Regents Of The University Of Nebraska Robotic surgical devices, systems and related methods
EP3191009B1 (en) 2014-09-12 2021-03-31 Board of Regents of the University of Nebraska Quick-release end effectors and related systems
WO2016077478A1 (en) 2014-11-11 2016-05-19 Board Of Regents Of The University Of Nebraska Robotic device with compact joint design and related systems and methods
CN108472030B (zh) 2015-08-03 2021-06-18 内布拉斯加大学董事会 机器人手术装置系统及相关方法
US10751136B2 (en) 2016-05-18 2020-08-25 Virtual Incision Corporation Robotic surgical devices, systems and related methods
CN110248614B (zh) 2016-08-25 2023-04-18 内布拉斯加大学董事会 快速释放工具耦接器以及相关系统和方法
WO2018045036A1 (en) 2016-08-30 2018-03-08 Board Of Regents Of The University Of Nebraska Robotic device with compact joint design and an additional degree of freedom and related systems and methods
WO2018098319A1 (en) 2016-11-22 2018-05-31 Board Of Regents Of The University Of Nebraska Improved gross positioning device and related systems and methods
WO2018102430A1 (en) 2016-11-29 2018-06-07 Virtual Incision Corporation User controller with user presence detection and related systems and methods
WO2018112199A1 (en) 2016-12-14 2018-06-21 Virtual Incision Corporation Releasable attachment device for coupling to medical devices and related systems and methods
EP3687370B1 (en) 2017-09-27 2024-11-20 Virtual Incision Corporation Robotic surgical devices with tracking camera technology and related systems
WO2019136360A1 (en) 2018-01-05 2019-07-11 Board Of Regents Of The University Of Nebraska Single-arm robotic device with compact joint design and related systems and methods
CN114302665B (zh) 2019-01-07 2025-12-19 虚拟切割有限公司 机器人辅助手术系统以及相关装置和方法
JP2023532977A (ja) 2020-07-06 2023-08-01 バーチャル インシジョン コーポレイション 外科用ロボット位置決めシステム並びに関連する装置及び方法

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995010515A1 (en) * 1993-10-15 1995-04-20 Schering Corporation Tricyclic carbamate compounds useful for inhibition of g-protein function and for treatment of proliferative diseases
WO1995010516A1 (en) * 1993-10-15 1995-04-20 Schering Corporation Tricyclic amide and urea compounds useful for inhibition of g-protein function and for treatment of proliferative diseases

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5089496A (en) * 1986-10-31 1992-02-18 Schering Corporation Benzo[5,6]cycloheptapyridine compounds, compositions and method of treating allergies
US4826853A (en) * 1986-10-31 1989-05-02 Schering Corporation 6,11-Dihydro-11-(N-substituted-4-piperidylidene)-5H-benzo(5,6)cyclohepta(1,2-B)pyridines and compositions and methods of use
JPH0676403B2 (ja) * 1991-01-18 1994-09-28 エスエス製薬株式会社 新規なベンゾ[5,6 シクロヘプタ[1,2−b ピリジン誘導体及びこれを含有する抗アレルギー剤
EP0723539B1 (en) * 1993-10-15 2001-12-12 Schering Corporation Tricyclic sulfonamide compounds useful for inhibition of g-protein function and for treatment of proliferative diseases
US5719148A (en) * 1993-10-15 1998-02-17 Schering Corporation Tricyclic amide and urea compounds useful for inhibition of g-protein function and for treatment of proliferative diseases
US5700806A (en) * 1995-03-24 1997-12-23 Schering Corporation Tricyclic amide and urea compounds useful for inhibition of G-protein function and for treatment of proliferative diseases
IL117798A (en) * 1995-04-07 2001-11-25 Schering Plough Corp Tricyclic compounds useful for inhibiting the function of protein - G and for the treatment of malignant diseases, and pharmaceutical preparations containing them
CZ292791B6 (cs) * 1995-12-22 2003-12-17 Schering Corporation Tricyklické amidy, které se používají pro inhibici G-proteinové funkce a k léčení proliferativních onemocnění

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995010515A1 (en) * 1993-10-15 1995-04-20 Schering Corporation Tricyclic carbamate compounds useful for inhibition of g-protein function and for treatment of proliferative diseases
WO1995010516A1 (en) * 1993-10-15 1995-04-20 Schering Corporation Tricyclic amide and urea compounds useful for inhibition of g-protein function and for treatment of proliferative diseases

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
J.BIO.CHEM.VOL.270(5) 1995-01-01 W.ROBERT.BISHOP.ET.AL. *

Also Published As

Publication number Publication date
DE69732120D1 (de) 2005-02-03
NO991234D0 (no) 1999-03-12
IL128928A0 (en) 2000-02-17
TR199901276T2 (xx) 1999-09-21
BR9712831A (pt) 1999-11-16
KR20000036120A (ko) 2000-06-26
PL332242A1 (en) 1999-08-30
SK33899A3 (en) 2000-02-14
ID21699A (id) 1999-07-15
JP2001500510A (ja) 2001-01-16
ATE286046T1 (de) 2005-01-15
CA2266016A1 (en) 1998-03-19
HUP0000121A2 (hu) 2001-04-28
CA2266016C (en) 2004-06-01
DE69732120T2 (de) 2005-12-08
EP0929545A1 (en) 1999-07-21
NO991234L (no) 1999-05-12
ES2235252T3 (es) 2005-07-01
EP0929545B1 (en) 2004-12-29
NZ334453A (en) 2000-08-25
WO1998011093A1 (en) 1998-03-19
CN1237165A (zh) 1999-12-01
CZ84399A3 (cs) 1999-11-17
AU4337997A (en) 1998-04-02

Similar Documents

Publication Publication Date Title
CN1237165A (zh) 法呢基蛋白转移酶的三环抑制剂
CN1094937C (zh) 具抑制法呢基转化酶作用的喹唑啉酮类
CN1209127A (zh) 三环酰胺类用于抑制g-蛋白功能及治疗增生疾病
CN1365281A (zh) 金属蛋白酶抑制剂
CN1238770A (zh) 为法呢基蛋白转移酶抑制剂的三环抗肿瘤化合物
CN1422269A (zh) 1h-咪唑并吡啶衍生物
HK1049834A1 (zh) 用作磷酸二酯酶抑制剂的5-(2-取代的-5-杂环基磺酰基吡啶-3-基)-二氢吡唑并[4,3-d]嘧啶-7-酮类化合物
CN1193276A (zh) 氧化-角鲨烯环化酶抑制剂的降低血中胆甾醇的应用
CN1135218A (zh) 哌啶类衍生物
CN1684951A (zh) 新的嘧啶胺衍生物及其用途
CN1067889A (zh) 取代的n-(1-烷基-3-羟基-4-哌啶基)苯甲酰胺的制备方法
CN1127498C (zh) 吡啶衍生物、制备吡啶衍生物的方法及其中间体
CN1070488C (zh) 杀灭螺旋杆菌用的取代芳烷基硫代烷基硫代吡啶
CN1122031C (zh) 用作法呢基蛋白转移酶抑制剂的取代的苯并芳庚并吡啶衍生物
CN1267289A (zh) 用于抑制g-蛋白功能和治疗增生性疾病的羧基哌啶基乙酰胺三环化合物(法呢基蛋白转移酶抑制剂)
CN1119345C (zh) 用作法呢基蛋白转移酶抑制剂的苯并(5.6)环庚并吡啶化合物
CN1237169A (zh) 用于抑制g-蛋白功能并用于治疗增生性疾病的三环化合物
CN1237164A (zh) 用作法呢基-蛋白转移酶抑制剂的化合物
CN1314345A (zh) 新的哌啶-4-磺酰胺化合物、其制备方法和含有它们的药物组合物
CN1585762A (zh) 作为nmda受体配体的吡啶衍生物
CN1237170A (zh) 用作法呢基蛋白转移酶抑制剂的新的三环哌啶基化合物
CN1237176A (zh) 用作fpt抑制剂的三环化合物
CN1311785A (zh) 作为甘氨酸拮抗剂的四氢喹啉衍生物
CN1267297A (zh) 用作法呢基蛋白转移酶抑制剂的苯并(5.6)环庚并吡啶环脲和内酰胺
CN1267288A (zh) 用作法呢基蛋白转移酶抑制剂的三环酮酰胺衍生物

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C19 Lapse of patent right due to non-payment of the annual fee
CF01 Termination of patent right due to non-payment of annual fee